discipline summaries
lent program acceptable to the College, and
shall forthwith thereafter provide proof of
completion thereof to the College.
(b) Dr. Reid shall participate in and successfully
complete the next available course on “Understanding Boundaries in Managing the Risks
Inherent in the Doctor-Patient Relationship”
offered by Western University, or an equivalent
program acceptable to the College, and shall
forthwith thereafter provide proof of completion thereof to the College.
(c) Until Dr. Reid has delivered to the College an
executed undertaking from a clinical supervisor
who has been approved by the College or if the
clinical supervisor(s) resigns or cannot otherwise
fulfill his or her undertaking, Dr. Reid shall
not issue new prescriptions or renew existing
prescriptions for any of the following:
(i) narcotic drugs (from the Narcotic Control
Regulations made under the Controlled
Drugs and Substances Act, S.C., 1996, c.
19);
(ii) narcotic preparations (from the Narcotic
Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996,
c. 19);
(iii) controlled drugs (from Schedule G of the
Regulations under the Food and Drugs Act,
S.C., 1985, c. F-27);
(iv) benzodiazepines/other targeted substances
(from the Benzodiazepines and Other Targeted Substances Regulations made under
the Controlled Drugs and Substances Act.,
S.C., 1996, c. 19); or
(v) a ll other monitored drugs (as defined under
the Narcotic Safety and Awareness Act, S.O.
2010, c. 22 as noted in Schedule “D”) and
as amended from time to time.
(d) While Dr. Reid is subject to the restriction
regarding narcotics or restricted substances set
out above at paragraph (c), the following statement shall appear on the public register: Dr.
Reid shall not issue new prescriptions or renew
existing prescriptions for any of the following
(“narcotics or restricted substances”):
(i) narcotic drugs (from the Narcotic Control
Regulations made under the Controlled
62
Dialogue Issue 3, 2015
Drugs and Substances Act, S.C., 1996, c.
19);
(ii) n
arcotic preparations (from the Narcotic
Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996,
c. 19);
(iii) c ontrolled drugs (from Schedule G of the
Regulations under the Food and Drugs Act,
S.C., 1985, c. F-27);
(iv) benzodiazepines/other targeted substances
(from the Benzodiazepines and Other Targeted Substances Regulations made under
the Controlled Drugs and Substances Act.,
S.C., 1996, c. 19); or
(v) a ll other monitored drugs (as defined under
the Narcotic Safety and Awareness Act, S.O.
2010, c. 22) and as amended from time to
time.
(e) While Dr. Reid is subject to the restriction regarding narcotics or restricted substances set out
above, Dr. Reid shall post a clearly visible sign
in the waiting room of every location at which
he practises. For further clarity, the sign shall
state that “Dr. Reid shall not prescribe narcotic
drugs, narcotic preparations, benzodiazepines,
other targeted substances, controlled drugs and
all other monitored drugs.”
(f ) A
fter Dr. Reid has delivered an executed undertaking from an approved clinical supervisor(s) to
the College as described above. Dr. Reid shall issue new prescriptions or renew existing prescriptions for narcotics or restricted substances only
in accordance with the remediation program
described below, until the remediation program
has been completed:
(i) Throughout the remediation program, Dr.
Reid shall maintain an up-to-date log of all
prescriptions issued or renewed for narcotics
or restricted substances, in a form approved
by the College (“the Narcotics Log”).
(ii) In Phase One of the remediation program,
Dr. Reid shall prescribe narcotics or restricted substances to no more than 20 patients,
who will be selected in cooperation with
and approved by the clinical supervisor(s).
Dr. Reid shall submit an